ABN AMRO Bank N.V.ABN AMRO Bank N.V.

Institutional investor · Portfolio as of Q1 2024

SEC EDGAR SourceSEC Filings

Top Holdings152 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction

MICROSOFT CORP

976,021$410.8M6.1%$279.58+48.55%
5 qtrssince 2023-Q1
Increased
61

LINDE PLC

878,832$408.4M6.1%$339.30+33.80%
5 qtrssince 2023-Q1
Decreased
0

INGERSOLL-RAND PLC

1.3M$405.1M6.1%$178.13+66.13%
5 qtrssince 2023-Q1
Decreased
0

VISA INC-CLASS A SHARES

1.1M$293.8M4.4%$220.74+24.07%
5 qtrssince 2023-Q1
Decreased
0

MERCK & CO. INC.

2.1M$283.3M4.2%$97.53+27.74%
5 qtrssince 2023-Q1
Increased
57

WALT DISNEY CO/THE

2.2M$271.5M4.1%$93.43+28.37%
5 qtrssince 2023-Q1
Increased
58

UNITEDHEALTH GROUP INC

537,066$265.9M4.0%$447.85+6.56%
5 qtrssince 2023-Q1
Increased
56

ACCENTURE PLC-CL A

762,358$264.4M4.0%$276.51+19.61%
5 qtrssince 2023-Q1
Increased
65

XYLEM INC

2M$262.1M3.9%$98.62+28.46%
5 qtrssince 2023-Q1
Decreased
0

TJX COMPANIES INC

2.1M$215.9M3.2%$81.22+20.94%
5 qtrssince 2023-Q1
Decreased
0

ABBVIE INC

1.1M$208.5M3.1%$167.23+0.10%
5 qtrssince 2023-Q1
Increased
91

METLIFE INC

2.6M$196M2.9%$54.08+27.47%
5 qtrssince 2023-Q1
Decreased
0

S&P GLOBAL INC

458,222$195.1M2.9%$343.02+22.42%
5 qtrssince 2023-Q1
Decreased
0

REGENERON PHARMACEUTICALS

198,910$191.6M2.9%$944.95+1.29%
4 qtrssince 2023-Q2
Increased
84

ECOLAB INC

777,619$179.7M2.7%$161.11+40.83%
5 qtrssince 2023-Q1
Decreased
0

EBAY INC

3.3M$175.5M2.6%$41.69+22.98%
5 qtrssince 2023-Q1
Decreased
0
EQIXEQIX
REIT

EQUINIX INC

212,349$175.4M2.6%$663.41+19.78%
5 qtrssince 2023-Q1
Decreased
0

ADOBE INC

345,618$174.5M2.6%$493.97+2.15%
5 qtrssince 2023-Q1
Increased
52

NVIDIA CORP

189,432$171.3M2.6%$71.77+25.83%
5 qtrssince 2023-Q1
Increased
84

PROCTER & GAMBLE CO/THE

1M$167.8M2.5%$136.36+11.34%
5 qtrssince 2023-Q1
Increased
55
$6.7B
AUM
152
Positions
Q1 2024
Filing
Rating · 3.0
Quarterly Portfolio Change
+10%Q2'23$4.9B+13%Q3'23$5.6B+9%Q4'23$6.1B+10%Q1'24$6.7B
Activity profile
$ moved · Q1'24
New1%Increased54%Decreased37%Exited8%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 3.6 quarters
<1Q6%1-4Q12%1-2Y80%2Y+2%

ABN AMRO Bank N.V. manages $6.7B across 152 positions as of Q1 2024. Top holdings: MSFT (6.1%), LIN (6.1%), TT (6.1%). Fund DNA: Steady Compounder. HoldingsIntel Rating: 3/5.0.

Q1 2024 Summary

Active quarter - 10 new positions, 13 exits, 65 increased. Top move: ABBV (INCREASED, conviction 91). Portfolio: $6.7B across 152 positions.

Top holdings by portfolio weight

Total AUM$7B
MSFT6.14%
LIN6.10%
TT6.06%
V4.39%
MRK4.24%
DIS4.06%
UNH3.97%
ACN3.95%
XYL3.92%
TJX3.23%
Other3.12%

Portfolio allocation by GICS sector

Sectors11
Technology21.34%
Healthcare19.91%
Financial Services12.89%
Industrials12.45%
Basic Materials9.82%
Consumer Cyclical8.92%
Communication Services5.68%
Consumer Defensive5.50%
Real Estate3.16%
Utilities0.19%
Other0.12%

Behavioral investing profile

Checking access…
Steady Compounder- primarily Technology, Healthcare, Financial Services
Compare DNA across all funds
7-dimension quality assessment
Solid(3.0 / 5.0)
Track Record94
Conviction44
Concentration62
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
8Q
ALCALCALCON INC
Q3 2024 Q2 2026+21,023 shares+$1.3M
6Q
GOOGLGOOGLALPHABET INC-CL A
Q1 2025 Q2 2026+472,832 shares+$215.9M
5Q
MDLZMDLZMONDELEZ INTERNATIONAL INC-A
Q2 2025 Q2 2026+27,175 shares+$1.1M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used